Brevan Howard Capital Management’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246K Buy
39,576
+22,110
+127% +$130K ﹤0.01% 1806
2026
Q1
$77.2K Sell
17,466
-54,534
-76% -$323K ﹤0.01% 2058
2025
Q4
$386K Buy
72,000
+10,880
+18% +$86.5K ﹤0.01% 1235
2025
Q3
$588K Buy
+61,120
New +$564K ﹤0.01% 1199
2024
Q2
– Sell
-24,359
Closed -$101K – 1062
2024
Q1
$101K Buy
+24,359
New +$75.1K ﹤0.01% 893

Other funds holding ASPI

Brevan Howard Capital Management's ASPI Position: Q2 2026 in Review

Brevan Howard Capital Management increased its ASP Isotopes (ASPI) stake by 127% in Q2 2026, buying an estimated $130K and bringing the position to 39,576 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1806.

Brevan Howard Capital Management first reported a position in ASPI in Q1 2024 and has held it in 5 quarters since. The position peaked at $588K in Q3 2025. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.

  • Brevan Howard Capital Management held 39,576 shares of ASP Isotopes worth $246K as of Q2 2026.
  • Brevan Howard Capital Management bought 22,110 ASP Isotopes shares in Q2 2026, an estimated $130K.
  • ASP Isotopes made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1806 holding.
  • Brevan Howard Capital Management first reported a position in ASP Isotopes in Q1 2024 and has held it in 5 quarters since.
  • Brevan Howard Capital Management's ASP Isotopes position peaked at $588K in Q3 2025.
  • 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.